BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38457412)

  • 1. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
    Nowicka N; Zglejc-Waszak K; Juranek J; Korytko A; Wąsowicz K; Chmielewska-Krzesińska M; Wojtkiewicz J
    PLoS One; 2024; 19(3):e0299567. PubMed ID: 38457412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice.
    Nowicka N; Szymańska K; Juranek J; Zglejc-Waszak K; Korytko A; Załęcki M; Chmielewska-Krzesińska M; Wąsowicz K; Wojtkiewicz J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1
    Lee JD; McDonald TS; Fung JNT; Woodruff TM
    Mol Neurobiol; 2020 Oct; 57(10):4143-4155. PubMed ID: 32676989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of RAGE inhibition on the progression of the disease in hSOD1
    Liu L; Killoy KM; Vargas MR; Yamamoto Y; Pehar M
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00636. PubMed ID: 32776498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
    Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1
    Lee JD; Liu N; Levin SC; Ottosson L; Andersson U; Harris HE; Woodruff TM
    J Neuroinflammation; 2019 Feb; 16(1):45. PubMed ID: 30782181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
    Liu X; Zhang J; Li J; Song C; Shi Y
    Mol Metab; 2022 Sep; 63():101536. PubMed ID: 35772643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
    Bette M; Cors E; Kresse C; Schütz B
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
    Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
    Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ; Ackerley S; Davies KE; Talbot K
    Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1
    Hernández S; Salvany S; Casanovas A; Piedrafita L; Soto-Bernardini MC; Tarabal O; Blasco A; Gras S; Gatius A; Schwab MH; Calderó J; Esquerda JE
    Neurotherapeutics; 2023 Oct; 20(6):1820-1834. PubMed ID: 37733208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1
    Granatiero V; Sayles NM; Savino AM; Konrad C; Kharas MG; Kawamata H; Manfredi G
    Autophagy; 2021 Dec; 17(12):4029-4042. PubMed ID: 33749521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.